ICU Medical Inc (ICUI)

Profitability ratios

Return on sales

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Gross profit margin 34.55% 32.20% 31.79% 31.79% 32.14% 33.04% 32.51% 31.27% 30.60% 31.84% 33.23% 35.53% 37.34% 37.33% 36.76% 35.92% 36.31% 36.00% 36.69% 36.24%
Operating profit margin 2.41% 0.02% 0.65% 0.45% 1.14% -0.19% -0.74% -0.86% -2.04% 1.31% 3.08% 5.80% 9.36% 9.75% 8.88% 7.83% 7.72% 7.03% 7.68% 8.15%
Pretax margin -2.77% -4.74% -4.27% -4.51% -3.47% -2.80% -3.44% -3.17% -5.02% -3.41% -0.58% 2.68% 9.36% 10.03% 9.24% 8.27% 7.67% 6.97% 7.56% 8.04%
Net profit margin -4.94% -4.74% -3.07% -2.63% -1.31% -1.25% -2.11% -2.00% -3.26% -1.90% 0.31% 2.68% 7.84% 8.44% 8.07% 7.44% 6.83% 6.43% 6.61% 6.87%

ICU Medical Inc's profitability ratios have shown fluctuations over the analyzed periods.

1. Gross profit margin has been declining from 36.24% in March 2020 to 34.55% in December 2024, with some variability in between.

2. Operating profit margin experienced a similar trend, decreasing from 8.15% in March 2020 to 2.41% in December 2024, with significant drops in the latter half of the analysis period.

3. Pretax margin followed a downward trajectory, starting at 8.04% in March 2020 and ending at -2.77% in December 2024, with negative margins recorded in the latter years.

4. Net profit margin also decreased steadily, from 6.87% in March 2020 to -4.94% in December 2024, reflecting a challenging profitability situation for the company.

Overall, ICU Medical Inc's profitability has come under pressure, with margins showing a consistent decline over the analyzed period, indicating potential challenges in managing costs and generating profits.


Return on investment

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating return on assets (Operating ROA) 1.37% 0.01% 0.35% 0.24% 0.59% -0.10% -0.38% -0.44% -1.03% 0.60% 1.20% 1.88% 6.55% 6.87% 6.30% 5.59% 5.57% 5.14% 5.18% 5.67%
Return on assets (ROA) -2.80% -2.58% -1.65% -1.38% -0.68% -0.64% -1.09% -1.03% -1.65% -0.87% 0.12% 0.87% 5.48% 5.95% 5.73% 5.31% 4.93% 4.70% 4.46% 4.78%
Return on total capital 3.35% 1.36% 1.48% 0.79% 1.74% 2.12% 1.23% 0.71% -2.13% -1.23% 0.96% 2.56% 7.68% 8.07% 7.95% 7.26% 6.91% 6.67% 6.81% 7.43%
Return on equity (ROE) -5.99% -5.42% -3.47% -2.87% -1.40% -1.34% -2.29% -2.19% -3.55% -1.93% 0.26% 1.90% 6.38% 6.88% 6.63% 6.17% 5.78% 5.60% 5.88% 6.31%

ICU Medical Inc's profitability ratios show a declining trend over the years.

- Operating return on assets (Operating ROA) peaked at 6.87% on September 30, 2021, but then significantly decreased to 0.01% on December 31, 2024. This indicates a substantial decline in the company's ability to generate operating profits from its assets over the period.

- Return on assets (ROA) also followed a downward trajectory, reaching -2.80% by December 31, 2024. This indicates a negative return on the company's total assets, implying inefficiency in asset utilization and overall profitability.

- Return on total capital displayed fluctuations, with a decrease from 8.07% on September 30, 2021, to 1.36% on September 30, 2024. This suggests variations in the company's profitability relative to its total invested capital.

- Return on equity (ROE) plunged from 6.88% on September 30, 2021, to -5.99% on December 31, 2024. Such a significant decline in ROE indicates a downturn in the company's ability to generate profits for its shareholders.

Overall, the declining trend in profitability ratios for ICU Medical Inc suggests challenges in maintaining operational efficiency and generating sustainable returns on both assets and equity.